Potential Sciences launches UK AI drug discovery startup with seed funding
Overview
Potential Sciences, a British AI startup, launched on November 5 with seed funding in the tens of millions of dollars from SovAI, the UK government's AI venture capital fund, and Twin Path Ventures, according to Wired.
The company plans to generate large synthetic chemical datasets by simulating atomic and molecular interactions with physics, then use them to train AI models that predict drug candidates.
The founder says this approach could make treatments for rare diseases economical. Researchers quoted in the report note that clinical testing still takes a long time regardless of faster drug design.
Written by AI from the articles below · updated Nov 5, 8:06 AM ET
Check the sources:
Article timeline
The articles in this story. Times are ET.
- Wired · AINewsFinding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work
AIPotential Sciences, a British AI startup, launched on November 5 with seed funding in the tens of millions of dollars from SovAI, the UK government's AI venture capital fund, and Twin Path Ventures. The company plans to generate large synthetic chemical datasets by simulating atomic and molecular interactions with physics, then use them to train AI models that predict drug candidates. Its founder says this could make treatments for rare diseases economical, while researchers note that clinical testing still takes long regardless of faster design.
Heat Trend
Not enough continuous observations to show a trend yet.